Please provide your email address to receive an email when new articles are posted on . Patients were treated with intravenous ertapenem for an average of 13.1 weeks. During a 7-week, posttherapy ...

Oral antibiotics may be a safe alternative to receiving prolonged intravenous (IV) antibiotics, according to a recent observational study published in JAMA Network Open. Overall, 14.3% of patients who ...

Compared with usual care, procalcitonin-guided antibiotic therapy does not reduce the duration of intravenous antibiotic treatment in children hospitalised with bacterial infections, shows a new trial ...

In patients with naïve advanced non-small cell lung cancer (NSCLC) and high PD-LI expression who are treated with pembrolizumab, the use of intravenous (IV) antibiotics may negatively impact ...

Vatican City — Pope Francis was in a "good and stable" condition Monday but was receiving antibiotics intravenously and would limit his activities for a few days to regain strength and fight off a ...

BALTIMORE -- There was no benefit with a longer- versus shorter-duration prophylactic antibiotic regimen in reducing surgical site infections after endoprosthetic reconstruction for lower-extremity ...

-CONTEPO is a potential first-in-class intravenous antibiotic in U.S. for the treatment of complicated urinary tract infections The NDA for CONTEPO was resubmitted based on the outcome and final ...

An experimental oral antibiotic is more than 90% effective in treating complicated urinary tract infections caused by multidrug-resistant bacteria, researchers say. The drug, Tebipenem pivoxil ...

Meitheal Pharmaceuticals has gotten federal approval for a new kind of antibiotic for use on hospitalized patients with urinary tract infections, a major step in the Chicago biopharma company's ...

For patients with uncomplicated acute appendicitis, the noninferiority of oral antibiotics alone compared with a combination of intravenous and oral antibiotics could not be demonstrated in a ...

Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds - according to a University of East Anglia study.